Advancements in personalized medicine and other innovations are transforming the way dosage forms are viewed.

Reshaping Dosage Forms

This study aimed to develop a taste-masked drug resin complex using the ion exchange resin Kyron T-114.

Development of Taste-Masked Oral Dispersible Tablets of Cefpodoxime Proxetil

Novel genetic engineering technologies are transforming the design and manufacture of bispecific antibodies, which are emerging as a promising new class of biologics.

Frontrunners in Bispecific Antibodies

Topic

Articles

Coherus BioSciences, Daiichi Sankyo Form Biosimilar Pact; Sandoz Agrees to Acquire Fougera Pharmaceuticals; and More.

Week of May 7, 2012: Coherus BioSciences, Daiichi Sankyo Form Biosimilar Pact; Sandoz Agrees to Acquire Fougera Pharmaceuticals; and More

AstraZeneca's CEO David Brennan To Retire; PRA, Amgen Reach New Biosimilar Agreement; and More.

Week of Apr. 30, 2012: AstraZeneca's CEO David Brennan to Retire; PRA, Amgen Reach New Biosimilar Agreement; and More

Stephanie Sutton was an assistant editor at Pharmaceutical Technology Europe.

A technical forum featuring Tim Freeman of Freeman Technology and Carl Levoguer of Malvern Instruments.

Optimizing Tableting Processes with Quality by Design

Patricia Van Arnum was executive editor of Pharmaceutical Technology.

The Obama administration details five strategic imperatives to drive bioscience research as a means of economic growth.

White House Releases National Bioeconomy Blueprint

Angie Drakulich was editorial director of Pharmaceutical Technology.

Industry experts working with extended-release injectables discuss challenges and solutions to formulating and manufacturing these complex products.

Meeting Manufacturing Challenges Tied to Extended-Release Injectables

Amy Ritter was Scientific Editor, BioPharm International.

In this technical forum, experts describe different methods of rapid microbial testing and their applications.

Rapid Microbial Testing

Closed-vial technology is an alternative to traditional glass vial filling that reduces the risk of contamination for the patient, simplifies the filling process, and provides easier handling for healthcare providers.

Using Closed-Vial Technology in Aseptic Filling

The European Commission is offering a EUR 2-million ($2.64 million) inducement prize to encourage innovation in the area of cold-chain logistics and vaccine stability.

EC Offers Cash Prize for Vaccine Stability

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The growing use of high-potency APIs is leading to changes in how the pharmaceutical industry looks at containment.

Achieving Containment in High-Potency Manufacturing

FDA has released a final guidance describing cGMP for preparing media fills for validation of aseptic preparations for positron emission tomography drugs.